Implications for the assay and biological properties of interleukin-3 Results of a WHO international collaborative study
- 17 July 1996
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 194 (1) , 1-12
- https://doi.org/10.1016/0022-1759(96)00068-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of recombinant human interleukin-3 on haematological recovery from chemotherapy-induced myelosuppressionBritish Journal of Haematology, 1994
- Glycosylation does not affect in-vitro biological activity of interleukin-3Cytokine, 1993
- Effects of recombinant human interleukin-3 in aplastic anemiaBlood, 1990
- Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromesBlood, 1990
- Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietinJournal of Cellular Physiology, 1989
- Selective growth response to IL‐3 of a human leukaemic cell line with megakaryoblastic featuresBritish Journal of Haematology, 1988
- Characterization of a human multilineage-colony-stimulating factor cDNA clone identified by a conserved noncoding sequence in mouse interleukin-3Gene, 1987
- Human IL-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3Cell, 1986
- Molecular cloning of cDNA for murine interleukin-3Nature, 1984